108Labs Press

108Labs' science is disruptive.
If you don't know, now you know.

108Labs in the News

June 22, 2021 - Nutrition insight
April 30, 2021 - DNA Weekly
march 30, 2021 - GREEn queen
March 10, 2021 - Nutrition insight
March 9, 2021 - Dairy report

108Labs, LLC Press Releases

March 21, 2022 - 108Labs launches M2 Magic of Milk Platform, Pure Human Milk, M2Foods, and M2Health
June 20, 2021 - 108Labs is building the first autonomous milk cellufacturing® facility in Hillsborough, NC
March 8, 2021 - 108Labs launches Colostrupedics™ whole-human infant formula with secretory antibodies

108Labs Articles

March 8, 2021 - SIgA what, SIgA who?
Feb 17, 2021 - 108Labs licenses drugs and biologicals derived from mammary cell agriculture and whole-human milk antibodies to NeutraSiga Therapeutics, Inc.
Feb 18, 2021 - NeutraSiga Therapeutics launches Cellsimile personalized antibody therapeutics in partnership with 108Labs

Early 2020 - with 108Labs in stealth:
108Labs' Biomilq-branded Lactose-Casein announcement goes viral!

2-6-2020 The Spoon
2-6-2020 Ag Funder
2-11-2020 - New Harvest
2-18-2020 Food Processing
2-18-2020 - Fast Company
2-19-2020 Romper
2-19-2020 Live Kindly
2-21-2020 Daily Reporter
2-26-2020 Food Politics
2-27-2020 - Daily Mail
2-27-2020 - The Atlantic

Stealth until 2021

From 2013-2020, 108Labs,LLC has quietly pioneered mammary cell agriculture and is now poised to disrupt food and medicine to redefine alternative dairy state of the art with biosimilar mother’s milk nutraceuticals and therapeutics comprising mother’s milk molecules and secretory antibodies.

History
Have a nice day

For press inquires email:

press@108labs.net

Facebook Twitter Linkedin Medium

108Labs,LLC – All Rights Reserved © 2021 – info@108labs.net – Cellufacturing® since 2013​

Facebook Twitter Linkedin Medium

Cellufacturing® since 2013
108Labs, LLC All Rights Reserved © 2021